Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Clinical and Translational Medicine
|
May 3, 2023
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma
Yulong Han, Qiuzhong Pan, Zhixing Guo, et al.
The EMBO Journal
|
July 26, 2022
ECM dimensionality tunes actin tension to modulate endoplasmic reticulum function and spheroid phenotypes of mammary epithelial cells
FuiBoon Kai, Guanqing Ou, Richard W Tourdot, et al.
Clinical & Translational Immunology
|
March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Meng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
Nature Communications
|
May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Clinical and Translational Medicine
|
May 3, 2023
BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma
Yulong Han, Qiuzhong Pan, Zhixing Guo, et al.
The EMBO Journal
|
July 26, 2022
ECM dimensionality tunes actin tension to modulate endoplasmic reticulum function and spheroid phenotypes of mammary epithelial cells
FuiBoon Kai, Guanqing Ou, Richard W Tourdot, et al.
Clinical & Translational Immunology
|
March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Meng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
Nature Communications
|
May 21, 2016
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A Burger, Dan A Landau, Amaro Taylor-Weiner, et al.
Page
of 7